Total Funding
84
83
Total FundingPre-Seed raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
100199
Crane Biosciences develops gene therapies using RBCNPs to evade the immune system, aiming to cure genetic diseases.
About the Company
Crane Biosciences specializes in the development of innovative gene therapies using red blood cell-derived nanoparticles (RBCNPs). These therapies are designed to be invisible to the immune system, addressing a critical challenge in gene therapy by preventing immune system reactions. The company's approach aims to revolutionize the treatment
of diseases caused by genetic mutations, potentially offering cures and improving the lives of millions. Crane Biosciences combines biotechnology expertise with AI to enhance the development of its gene therapies, focusing on making a significant impact on human health through scientific innovation.
